Our Pharma Insights Blog
In pharmaceutical development, choosing the right regulatory pathway can significantly influence timelines, costs, and overall…
Every breakthrough medication starts somewhere. That somewhere is either a New Chemical Entity (NCE) or…
A Reference Listed Drug (RLD) is an FDA-approved drug product identified in the Orange Book…
Biosimilars and generics are both affordable alternatives to brand-name medications. These drugs play a crucial…
The year 2024 proved to be a turning point for pharmaceutical innovation. From oncology to…
When it comes to drugs, one of the most common questions patients ask is, Are…
Serialization was once a regulatory checkbox. Today, it’s the backbone of compliant, efficient, and transparent clinical…
This article, authored by our Founder Salim Shaikh in International Clinical Trial Magazine, explores how…
Generic drugs are essential to global healthcare, making treatments more affordable and accessible to the…
LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, today announced…
Ever wondered why some clinical trials get delayed even before patient recruitment begins? One of…
Selecting the right clinical trial supplier is a crucial step that can make or break…